Holdings of State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
SPDR SERIES TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 428.4M $ including 428.2M $ in equities, 99.9 %
- Positions
- 65 in 3 countries
- Top ten
- 22.2 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Definium Therapeutics Inc | 281,317 | 13.2M $ | 3.09 % |
| 2 | MBX BIOSCIENCES INC | 210,962 | 11.6M $ | 2.72 % |
| 3 | ALUMIS INC | 325,914 | 9.2M $ | 2.14 % |
| 4 | AtaiBeckley Inc | 1,729,574 | 9.1M $ | 2.13 % |
| 5 | Trevi Therapeutics Inc | 487,893 | 9.1M $ | 2.12 % |
| 6 | Enliven Therapeutics Inc | 176,696 | 9M $ | 2.09 % |
| 7 | AMYLYX PHARMACEUTICALS INC | 485,721 | 8.7M $ | 2.04 % |
| 8 | VERADERMICS INC | 70,310 | 8.6M $ | 2.02 % |
| 9 | Ligand Pharmaceuticals Inc | 26,334 | 8.3M $ | 1.94 % |
| 10 | Nuvation Bio Inc | 1,427,463 | 8.1M $ | 1.89 % |
| 11 | Edgewise Therapeutics Inc | 198,593 | 8.1M $ | 1.88 % |
| 12 | Nektar Therapeutics | 115,142 | 8M $ | 1.88 % |
| 13 | Liquidia Corp | 100,195 | 8M $ | 1.86 % |
| 14 | Maze Therapeutics Inc | 265,830 | 7.9M $ | 1.85 % |
| 15 | Harrow Inc | 182,110 | 7.7M $ | 1.81 % |
| 16 | EyePoint Inc | 530,232 | 7.6M $ | 1.77 % |
| 17 | Amneal Pharmaceuticals Inc | 426,750 | 7.4M $ | 1.72 % |
| 18 | OCULAR THERAPEUTIX INC | 748,033 | 7.3M $ | 1.71 % |
| 19 | Corcept Therapeutics Inc | 83,688 | 7.3M $ | 1.70 % |
| 20 | Crinetics Pharmaceuticals Inc | 190,494 | 7.1M $ | 1.66 % |
| 21 | Pacira BioSciences Inc | 279,152 | 7.1M $ | 1.65 % |
| 22 | Merck & Co Inc | 54,900 | 7.1M $ | 1.65 % |
| 23 | Indivior Pharmaceuticals Inc | 171,638 | 7M $ | 1.64 % |
| 24 | ELANCO ANIMAL HEALTH INC | 285,865 | 7M $ | 1.64 % |
| 25 | Johnson & Johnson | 27,417 | 7M $ | 1.63 % |
| 26 | Eli Lilly & Co | 5,757 | 6.9M $ | 1.61 % |
| 27 | JAZZ PHARMACEUTICALS PLC | 28,473 | 6.9M $ | 1.60 % |
| 28 | Collegium Pharmaceutical Inc | 187,866 | 6.8M $ | 1.59 % |
| 29 | Bristol-Myers Squibb Co | 117,586 | 6.8M $ | 1.58 % |
| 30 | Supernus Pharmaceuticals Inc | 144,999 | 6.7M $ | 1.57 % |
| 31 | ROYALTY PHARMA PLC | 119,915 | 6.7M $ | 1.57 % |
| 32 | TARSUS PHARMACEUTICALS INC | 106,709 | 6.7M $ | 1.57 % |
| 33 | WAVE LIFE SCIENCES LTD | 1,155,091 | 6.7M $ | 1.57 % |
| 34 | Harmony Biosciences Holdings Inc | 184,265 | 6.7M $ | 1.57 % |
| 35 | Organon & Co | 488,626 | 6.6M $ | 1.54 % |
| 36 | ANI Pharmaceuticals Inc | 79,881 | 6.6M $ | 1.54 % |
| 37 | VIATRIS INC | 414,570 | 6.6M $ | 1.54 % |
| 38 | Esperion Therapeutics Inc | 2,082,103 | 6.6M $ | 1.54 % |
| 39 | Axsome Therapeutics Inc | 26,541 | 6.5M $ | 1.52 % |
| 40 | Innoviva Inc | 284,255 | 6.5M $ | 1.51 % |
| 41 | BioAge Labs Inc | 262,153 | 6.4M $ | 1.50 % |
| 42 | Prestige Consumer Healthcare Inc | 133,070 | 6.3M $ | 1.47 % |
| 43 | Rapport Therapeutics Inc | 147,854 | 6.2M $ | 1.44 % |
| 44 | Pfizer Inc | 255,385 | 6.1M $ | 1.44 % |
| 45 | OMEROS CORP | 640,960 | 6.1M $ | 1.42 % |
| 46 | Perrigo Co PLC | 585,303 | 6.1M $ | 1.42 % |
| 47 | Xeris Biopharma Holdings Inc | 753,307 | 6M $ | 1.39 % |
| 48 | Zoetis Inc | 80,428 | 5.8M $ | 1.35 % |
| 49 | Eton Pharmaceuticals Inc | 154,434 | 5.6M $ | 1.30 % |
| 50 | Phibro Animal Health Corp | 175,209 | 5.5M $ | 1.28 % |
| 51 | Amphastar Pharmaceuticals Inc | 265,621 | 5.4M $ | 1.25 % |
| 52 | Arvinas Inc | 642,928 | 5.3M $ | 1.25 % |
| 53 | Zevra Therapeutics Inc | 369,377 | 5.3M $ | 1.24 % |
| 54 | Alto Neuroscience Inc | 190,203 | 5M $ | 1.17 % |
| 55 | Phathom Pharmaceuticals Inc | 419,786 | 4.6M $ | 1.06 % |
| 56 | Relmada Therapeutics Inc | 655,062 | 4.5M $ | 1.06 % |
| 57 | CorMedix Inc | 549,805 | 4.3M $ | 1.01 % |
| 58 | Septerna Inc | 126,696 | 4.2M $ | 0.99 % |
| 59 | Theravance Biopharma Inc | 241,097 | 4.1M $ | 0.96 % |
| 60 | Aclaris Therapeutics Inc | 723,948 | 3.8M $ | 0.89 % |
| 61 | LB Pharmaceuticals Inc | 105,171 | 3.4M $ | 0.80 % |
| 62 | Aquestive Therapeutics Inc | 787,651 | 3.3M $ | 0.76 % |
| 63 | FULCRUM THERAPEUTICS INC | 807,587 | 3M $ | 0.69 % |
| 64 | LEXICON PHARMACEUTICALS INC | 1,121,988 | 2.7M $ | 0.63 % |
| 65 | Evolus Inc | 325,329 | 2.3M $ | 0.53 % |
Sector breakdown
- Health care 12.4 %
- Unattributed 87.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 95.4 %
- Ireland 3.0 %
- Singapore 1.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 62 | 408.6M $ | 95.41 % |
| 2 | Ireland | 2 | 12.9M $ | 3.02 % |
| 3 | Singapore | 1 | 6.7M $ | 1.57 % |
Cite this page
Titelia. "Holdings of State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF". https://titelia.com/en/funds/S000012321